| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT05515315 | Induction Tislelizumab Combined With Chemotherapy Followed by Definitive… | Immunotherapy Esophagus Cancer | Recruiting |
| Early Phase 1 | |||
| NCT07458919 | Therapy for Advanced NSCLC With EGFR 19delins Mutation | Lung Cancer | Not Yet Recruiting |
| Not specified | |||
| NCT06772363 | SERS-Based Serum Molecular Spectral Screening for Hematogenous Metastasis | Lung Cancers | Not Yet Recruiting |
| NCT06772376 | SERS Sensor Based on CHA Reaction for EGFR Mutation Typing in Advanced Lung Cancer | Lung Cancer in Normal and Malignant Tumors | Not Yet Recruiting |
| NCT06775002 | SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type | Lung Cancer, Non-Small Cell | Not Yet Recruiting |
| NCT06775015 | SERS-Based Serum Molecular Spectral Detection of Invasive Lung Cancer | Lung Cancer Patients | Not Yet Recruiting |
| NCT06775587 | SERS-Based Serum Molecular Spectral Screening for Benign and Malignant Pulmonary… | Lung Cancer in Normal and Malignant Tumors | Not Yet Recruiting |
| NCT07093762 | Efficacy and Safety Analysis of First-Line ABCP Therapy in Advanced SMARCA4-Mutated NSCLC | Non Small Cell Lung Cancer | Not Yet Recruiting |